acute lymphoblastic leukaemia
Showing 1 - 25 of >10,000
Acute Lymphoblastic Leukaemia - Category Trial in Leicester (Ciprofloxacin, Antibiotic)
Recruiting
- Acute Lymphoblastic Leukaemia - Category
-
Leicester, United KingdomLeicester Royal Infirmary
Jul 5, 2022
B-cell Acute Lymphoblastic Leukemia (B-ALL) Trial in Worldwide (AZD0486)
Not yet recruiting
- B-cell Acute Lymphoblastic Leukemia (B-ALL)
-
Duarte, California
- +30 more
Nov 13, 2023
B Acute Lymphoblastic Leukemia Trial in London (PBLTT52CAR19)
Recruiting
- B Acute Lymphoblastic Leukemia
-
London, United KingdomGreat Ormond Street Hospital
Dec 15, 2021
ACUTE LYMPHOBLASTIC LEUKEMIA Trial (Inotuzumab ozogamicin, ALLR3)
Not yet recruiting
- ACUTE LYMPHOBLASTIC LEUKEMIA
- Inotuzumab ozogamicin
- ALLR3
- (no location specified)
Feb 17, 2023
Non-hodgkin Lymphoma, Acute Lymphoblastic Leukaemia, Chronic Lymphocytic Leukemia Trial in Tianjin (CC312)
Recruiting
- Non-hodgkin Lymphoma
- +2 more
- CC312
-
Tianjin, Tianjin, ChinaInstituteHBDH
Sep 12, 2023
Lymphoblastic Leukemia, Acute, Childhood, Lymphoblastic Leukemia, Lymphoblastic Leukemia, Acute Adult Trial in Singapore (CAR
Recruiting
- Lymphoblastic Leukemia, Acute, Childhood
- +6 more
- CAR T-cell therapy
-
Singapore, SingaporeAllen Yeoh Eng Juh
Sep 7, 2021
InO - A Retrospective Study of UK Patients With Leukaemia
Completed
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Inotuzumab Ozogamicin
-
Bristol, United Kingdom
- +3 more
Jan 27, 2022
Lymphoblastic Leukemia, Lymphoblastic Leukemia in Children, Lymphoblastic Leukemia, Acute Adult Trial in Singapore (Anti-CD19
Recruiting
- Lymphoblastic Leukemia
- +5 more
- Anti-CD19 CAR T-cells
-
Singapore, Singapore
- +1 more
Dec 4, 2022
Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +4 more
- Dasatinib
- +5 more
-
Utrecht, NetherlandsPrincess Máxima Center for Pediatric Oncology
Feb 20, 2023
Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,
Not yet recruiting
- Acute Lymphoblastic Leukemia, in Relapse
- +4 more
- Ruxolitinib
- +5 more
-
Utrecht, NetherlandsPrincess Máxima Center for Pediatric Oncology
Feb 16, 2023
Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,
Not yet recruiting
- Acute Lymphoblastic Leukemia, in Relapse
- +4 more
- Decitabine
- +3 more
-
Utrecht, NetherlandsPrincess Máxima Center for Pediatric Oncology
Feb 22, 2023
Childhood Acute Lymphoblastic Leukaemia: Follow-Up
Completed
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Recurrence
- Mode of relapse/SMN detection
-
Aarhus N, Denmark
- +4 more
Aug 31, 2021
Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,
Not yet recruiting
- Acute Lymphoblastic Leukemia, in Relapse
- +4 more
- Trametinib
- +4 more
-
Utrecht, NetherlandsPrincess Máxima Center for Pediatric Oncology
Dec 13, 2022
Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, Adult, Acute Lymphoblastic Leukemia, Pediatric Trial in Denmark,
Recruiting
- Acute Lymphoblastic Leukemia
- +4 more
-
Copenhagen, Denmark
- +16 more
Jan 26, 2022
Acute B-Cell Lymphoblastic Leukaemia Trial in Brazil (Spectrila®)
Recruiting
- Acute B-Cell Lymphoblastic Leukaemia
-
Belo Horizonte, Brazil
- +7 more
Aug 26, 2022
Lymphoblastic Leukemia, Lymphoblastic Leukemia, Acute, Childhood, Lymphoblastic Leukemia in Children Trial in Singapore (Phase
Recruiting
- Lymphoblastic Leukemia
- +4 more
- Phase I
- Phase II
-
Singapore, SingaporeKK Women's and Children's hospital
Jun 20, 2022
Lymphoblastic Leukemia, Acute, Childhood, Lymphoblastic Leukemia, Lymphoblastic Leukemia, Acute Adult Trial in Singapore (CAR
Recruiting
- Lymphoblastic Leukemia, Acute, Childhood
- +5 more
- CAR T-cell therapy
-
Singapore, SingaporeAllen Yeoh Eng Juh
Sep 7, 2021
B-cell Acute Lymphoblastic Leukemia Trial in Worldwide (UCART19)
Completed
- B-cell Acute Lymphoblastic Leukemia
- UCART19
-
Boston, Massachusetts
- +8 more
Sep 24, 2021
Refractory B-cell Acute Lymphoblastic Leukemia, Relapsed B-cell Acute Lymphoblastic Leukemia Trial in Worldwide (UCART19)
Completed
- Refractory B-cell Acute Lymphoblastic Leukemia
- Relapsed B-cell Acute Lymphoblastic Leukemia
- UCART19
-
Los Angeles, California
- +5 more
Sep 30, 2021
Health Care Utilisation Among Survivors of Childhood Acute
Completed
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Diagnosis of and treatment for Acute lymphoblastic leukaemia in childhood
-
Aarhus C, DenmarkDepartment of Public Health
Dec 1, 2020
Acute Lymphocytic Leukaemia; Acute Myeloid Leukaemia Refractory; Myelodysplastic Syndrome Trial in Australia, Netherlands,
Recruiting
- Acute Lymphocytic Leukaemia; Acute Myeloid Leukaemia Refractory; Myelodysplastic Syndrome
-
Duarte, California
- +12 more
Jan 4, 2023
Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Acute Myeloid Leukaemia Trial in United Kingdom (Reduced intensity haplodentical
Active, not recruiting
- Hodgkin's Lymphoma
- +8 more
- Reduced intensity haplodentical stem cell transplant
- Myeloablative haploidentical stem cell transplant
-
Birmingham, United Kingdom
- +11 more
Sep 27, 2021
Acute Lymphoblastic Leukemia Trial in United Kingdom (Fludarabine, Melphalan, Alemtuzumab)
Recruiting
- Acute Lymphoblastic Leukemia
- Fludarabine
- +5 more
-
Birmingham, United Kingdom
- +21 more
Oct 14, 2021
Philadelphia Chromosome-negative or BCR-ABL-negative, CD19-positive ALL Trial in Spain (blinatumomab)
Terminated
- Philadelphia Chromosome-negative or BCR-ABL-negative, CD19-positive ALL
-
Badalona, Barcelona, Spain
- +11 more
Jul 26, 2022